Cargando…

Tumor Cells Treated with Vaccinia Virus Can Activate the Alternative Pathway of Mouse Complement

Vaccinia virus has been shown to render mouse tumor cells highly immunogenic. Since we have demonstrated that induction of complement activating capacity on guinea pig tumor cells by Sendai virus infection causes the tumor cells to become immunogenic, we assumed that vaccinia virus infection of mous...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wakamiya, Nobutaka, Okada, Noriko, Wang, Yu‐Lan, Ito, Tetsuya, Ueda, Shigeharu, Kato, Shiro, Okada, Hidechika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1989
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917831/ https://www.ncbi.nlm.nih.gov/pubmed/2511185 http://dx.doi.org/10.1111/j.1349-7006.1989.tb01712.x

Ejemplares similares

EXPRESSION OF CR2 (C3d RECEPTOR) ON THE CELL MEMBRANES OF ADULT T CELL LEUKEMIA
por: Kai, Chieko, et al.
Publicado: (1988)

Disabling complement regulatory activities of vaccinia virus complement control protein reduces vaccinia virus pathogenicity
por: Bernet, John, et al.
Publicado: (2011)

Peptide therapy in sepsis and inflammation: a novel strategy to suppress inflammation
por: Okada, Hidechika, et al.
Publicado: (2012)

Complement biomarkers reflect the pathological status of neuromyelitis optica spectrum disorders
por: Miyamoto, Katsuichi, et al.
Publicado: (2023)

INDUCTION OF SKIN RESISTANCE TO VACCINIA VIRUS IN RABBITS BY VACCINIA-SOLUBLE EARLY ANTIGENS
por: Ueda, Y., et al.
Publicado: (1973)

The use of the vaccinia virus complement control protein (VCP) in the rat retina
por: Fernando, Nilisha, et al.
Publicado: (2018)

Spatio-temporal and dynamic regulation of neurofascin alternative splicing in mouse cerebellar neurons
por: Suzuki, Satoko, et al.
Publicado: (2017)

Alternative Routes of Zoonotic Vaccinia Virus Transmission, Brazil
por: Costa, Galileu B., et al.
Publicado: (2015)

C5a inhibitor protects against ischemia/reperfusion injury in rat small intestine
por: Tuboly, Eszter, et al.
Publicado: (2016)

Regulation of C3 Activation by the Alternative Complement Pathway in the Mouse Retina
por: Williams, Jennifer A. E., et al.
Publicado: (2016)

Generation of novel oncolytic vaccinia virus with improved intravenous efficacy through protection against complement-mediated lysis and evasion of neutralization by vaccinia virus-specific antibodies
por: Lee, Namhee, et al.
Publicado: (2023)

Fukushimura Brain Bank (FBB) -Based in a private geriatric hospital-
por: Akatsu, Hiroyasu, et al.
Publicado: (2012)

Antibody against Extracellular Vaccinia Virus (EV) Protects Mice through Complement and Fc Receptors
por: Cohen, Matthew E., et al.
Publicado: (2011)

Expanding the Repertoire of Modified Vaccinia Ankara-Based Vaccine Vectors via Genetic Complementation Strategies
por: Garber, David A., et al.
Publicado: (2009)

Disseminated gonococcal infection in a Japanese man with complement 7 deficiency with compound heterozygous variants: A case report
por: Kageyama, Misaki, et al.
Publicado: (2021)

Can Financial Support Reduce Suicide Mortality Rates?
por: Kato, Ryo, et al.
Publicado: (2019)

The alternative complement pathway revisited
por: Harboe, Morten, et al.
Publicado: (2008)

Toxoplasma Infection Induces Sustained Up-Regulation of Complement Factor B and C5a Receptor in the Mouse Brain via Microglial Activation: Implication for the Alternative Complement Pathway Activation and Anaphylatoxin Signaling in Cerebral Toxoplasmosis
por: Shinjyo, Noriko, et al.
Publicado: (2021)

Complement 1 Inhibitor Is a Regulator of the Alternative Complement Pathway
por: Jiang, Haixiang, et al.
Publicado: (2001)

Epidemiological analysis of bovine torovirus in Japan
por: Ito, Toshihiro, et al.
Publicado: (2007)

Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes
Publicado: (1982)

Vaccinia and Smallpox
Publicado: (1901)

Vaccinia and Smallpox
Publicado: (1855)

Variola and Vaccinia
por: Greenley, T. B.
Publicado: (1882)

THE ROLE OF INTERFERON IN VACCINIA VIRUS INFECTION OF MOUSE EMBRYO TISSUE CULTURE
por: Glasgow, Lowell A., et al.
Publicado: (1962)

Accidental Infection of Laboratory Worker with Vaccinia
por: Moussatché, Nissin, et al.
Publicado: (2003)

CTRP6 is an endogenous complement regulator that can effectively treat induced arthritis
por: Murayama, Masanori A., et al.
Publicado: (2015)

Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy
por: Luo, Wentian, et al.
Publicado: (2018)

Vaccinia Virus in Household Environment during Bovine Vaccinia Outbreak, Brazil
por: Assis, Felipe L., et al.
Publicado: (2013)

Complement Factor D as a Strategic Target for Regulating the Alternative Complement Pathway
por: Barratt, Jonathan, et al.
Publicado: (2021)

Investigation of Interaction of Vaccinia Virus Complement Control Protein and Curcumin with Complement Components C3 and C3b Using Quartz Crystal Microbalance with Dissipation Monitoring Technology
por: Kulkarni, Amod P., et al.
Publicado: (2010)

Whence Feral Vaccinia?
por: Condit, Richard C.
Publicado: (2010)

Attenuation of Vaccinia Virus
por: Yakubitskiy, S. N., et al.
Publicado: (2015)

Note on Vaccinia of the Eyelids
por: Berry, George A.
Publicado: (1890)

Generalised Vaccinia in Burma
por: Iyer, S. Rama
Publicado: (1919)

Mr. Whyte, on Vaccinia
por: Whyte, D.
Publicado: (1801)

Vaccinia and Pox-Virus
por: Chalikonda, Sricharan, et al.
Publicado: (2007)

Attenuated DNA damage repair delays therapy-related myeloid neoplasms in a mouse model
por: Tong, Kit I, et al.
Publicado: (2016)

THE ROLE OF PROPERDIN IN THE ALTERNATE PATHWAY OF COMPLEMENT ACTIVATION
por: Götze, Otto, et al.
Publicado: (1974)

Quantitative Modeling of the Alternative Pathway of the Complement System
por: Zewde, Nehemiah, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_l3eb7b4ndjcn31rd4q4pmjd0va